Aira Medical Intelligence bridges the gap between complex clinical science and strategic healthcare development.

Aira Medical Intelligence bridges the gap between complex clinical science and strategic healthcare development.

Aira Medical Intelligence bridges the gap between complex clinical science and strategic healthcare development.

Founded by Dr. Akira Kojima—a physician-scientist with specialized leadership in oncology drug development, Aira Medical Intelligence provides strategic medical advisory and data-driven intelligence for biopharma innovators.

We support biopharma innovators, clinical teams, and digital health initiatives with strategic medical advisory, trial intelligence, and consulting services designed to accelerate clinical development and improve patient care.

CORE CAPABILITIES

CORE CAPABILITIES


  • Phase 3 Competitive Intelligence & Market Mapping

  • Oncology Drug Development Advisory (Pre-IND to Regulatory approval)

  • Healthcare Digitalization / AI Integration

  • Health Economics & Real-World Evidence Strategy


  • Phase 3 Competitive Intelligence & Market Mapping

  • Oncology Drug Development Advisory (Pre-IND to Regulatory approval)

  • Healthcare Digitalization / AI Integration

  • Health Economics & Real-World Evidence Strategy

LEADERSHIP

Akira Kojima, MD MPH

Founder & Principal Medical Advisor

Physician with extensive leadership spanning clinical hematology/oncology and global drug development. Proven track record across Parexel, AstraZeneca, and Zymeworks.

© 2026 Aira Medical Intelligence LLC. All rights reserved.

© 2026 Aira Medical Intelligence LLC. All rights reserved.